Insiders Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Real-time Estimate Cboe BZX Other stock markets 20:02:29 27/06/2024 BST			5-day change	1st Jan Change
12.52 ^USD	+2.54%		+9.19%	+32.62%

05-07	JMP Securities Adjusts Enanta Pharmaceuticals Price Target to $22 From $23, Maintains Market Outperform Rating	MT
05-06	Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer	04-30	CI
Enanta Pharmaceuticals, Inc. Announces Retirement of Nathaniel S. Gardiner as Senior Vice President and General Counsel, Effective on or Before March 31, 2024	12-26	CI
Insider Sell: Enanta Pharmaceuticals	15/03/23	MT
Insider Sell: Enanta Pharmaceuticals	14/02/23	MT
Insider Sell: Enanta Pharmaceuticals	19/12/22	MT
Enanta Pharmaceuticals, Inc. Announces Appointment of Scott T. Rottinghaus to the Position of Senior Vice President and Chief Medical Officer	08/08/22	CI
Insider Sell: Enanta Pharmaceuticals	06/04/22	MT
Insider Sell: Enanta Pharmaceuticals	04/03/22	MT
Insider Sell: Enanta Pharmaceuticals	06/12/21	MT
Insider Sell: Enanta Pharmaceuticals	14/10/21	MT
Enanta Pharmaceuticals, Inc. Elects Yujiro S. Hata as Independent Director	23/08/21	CI
Enanta Pharmaceuticals, Inc. Announces Nomination of Clinical Candidate Edp-235, Its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of Covid-19	05/08/21	CI
Enanta Pharmaceuticals, Inc. Announces Retirement of Senior Vice President and Chief Medical Officer, Nathalie Adda in February 2022	14/07/21	CI
Enanta Pharmaceuticals, Inc. Appoints Brendan Luu as Senior Vice President, Business Development	26/01/21	CI
Insider Trends: 90-Day Insider Buying Trend at Enanta Pharmaceuticals Slowed with Sale of Shares	09/01/21	MT
Enanta Pharmaceuticals Announces the Appointment of John P. Devincenzo, M.D. as Vice President of Translational Virology	06/01/21	CI
Enanta Pharmaceuticals Announces the Appointment of Tara L. Kieffer, Ph.D. as Senior Vice President, New Product Strategy and Development	08/12/20	CI
Enanta Pharmaceuticals, Inc. Announces Resignation of George Golumbeski as Director	04/12/20	CI
Enanta Pharmaceuticals Appoints Mark Foletta to its Board of Directors	10/07/20	CI
Enanta Pharmaceuticals Appoints Mark G. Foletta to Board of Directors	29/06/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Insiders

Filters